The next board meeting for Xeris Biopharma Holdings Inc is on 08 May 2026 for the purpose of Xeris Biopharma Holdings Inc First Quarter Earnings Results for 2026See details
Xeris Biopharma Holdings Inc has a share price target of US$ 11, revenue growth forecast of 31.3%, and profit growth estimate of 3227.3% for FY26, based on top 7 analyst calls.